Trial intelligence / Profile preview

Safety and Efficacy of 17-Beta Estradiol in Atrophic Vaginitis Extension Study

NCT00464971Phase 3Completed

Sponsor
Novo Nordisk
Start
Jan 1995
Primary completion
Nov 1996
Modality
Hormone, Biologic
01

Overview

A Phase 3 trial of estradiol in atrophic vaginitis, sponsored by Novo Nordisk. Started Jan 1995; status: completed.

02

Drugs

estradiol
03

Conditions

atrophic vaginitis

Beyond the preview

Go deeper on NCT00464971.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00464971.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call